# A Proof-of-concept Trial for OPC 131461 in Patients Hospitalized for Worsening Heart Failure

> **NCT06795399** · PHASE2 · WITHDRAWN · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.**

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** OPC-131461
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06795399
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-04-30
- **Primary completion:** 2025-05-25
- **Final completion:** 2025-05-25
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No sites were initiated, no sites were activated, no patients were enrolled in this study.
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06795399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06795399, "A Proof-of-concept Trial for OPC 131461 in Patients Hospitalized for Worsening Heart Failure". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT06795399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*